From lead discovery to re-purposing of promising existing therapies, to predicting whole-body and target tissue drug exposure, to understanding interactions between treatment and disease in both the acute and chronic setting, to de-risking clinical trials and maximizing patient benefit, Simulations Plus has the tools and expertise to move your COVID-19 drug development program forward. Watch this video to learn what our divisional Presidents have committed to fighting the COVID-19 pandemic.
Hover over the elements for more information.